Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Biorem Inc
XTSX:BRM

Watchlist Manager
Biorem Inc Logo
Biorem Inc
XTSX:BRM
Watchlist
Price: 2.69 CAD 0.75% Market Closed
Market Cap: CA$43.2m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

BRM Price Targets Summary
Biorem Inc

Wall Street analysts forecast BRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRM is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

BRM Lowest Forecast
Wall Street Target
3.54 CAD
31% Upside
BRM Average Forecast
Wall Street Target
3.57 CAD
33% Upside
BRM Highest Forecast
Wall Street Target
3.68 CAD
37% Upside
Lowest
Price Target
3.54 CAD
31% Upside
Average
Price Target
3.57 CAD
33% Upside
Highest
Price Target
3.68 CAD
37% Upside
Biorem Inc Competitors:
Price Targets

Revenue
Forecast

9% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
9% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Biorem Inc's revenue is 9%. The projected CAGR for the next 2 years is 12%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Biorem Inc

Net Income
Forecast

N/A
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Biorem Inc's net income for the next 2 years is 23%.

What are analyst estimates?

See Also

Summary
BRM intrinsic value, competitors valuation, and company profile.
DCF Valuation
BRM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BRM stock valuation using valuation multiples.
Wall Street Estimates
BRM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BRM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BRM's stock price target?
Price Target
3.57 CAD

According to Wall Street analysts, the average 1-year price target for BRM is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

What is Biorem Inc's Revenue forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Biorem Inc's revenue is 9%. The projected CAGR for the next 2 years is 12%.

What is Biorem Inc's Net Income forecast?
Projected CAGR
23%

The compound annual growth rate of Biorem Inc's net income for the next 2 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.